Pathophysiology of ketoacidosis in Type 2 diabetes mellitus

Diabetic Medicine

Volumn 22, Issue 10, 2005, Pages 1414-1419

  Linfoot, P ^a   Bergstrom, C ^a   Ipp, Eli ^a  

^a HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

C peptide; Insulin; Ketoacidosis; Type 2 diabetes

Indexed keywords

BICARBONATE; C PEPTIDE; FATTY ACID; GLUCAGON; GLUCOSE; GROWTH HORMONE; INSULIN; OXOACID;

ADULT; AGED; ANION GAP; ARTICLE; BICARBONATE BLOOD LEVEL; CLINICAL ARTICLE; DIABETIC KETOACIDOSIS; FEMALE; GLUCAGON BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; HYPOINSULINEMIA; INSULIN RELEASE; INSULIN TREATMENT; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; STRESS;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES; C-PEPTIDE; DIABETES MELLITUS, TYPE 2; DIABETIC KETOACIDOSIS; EPINEPHRINE; FATTY ACIDS, NONESTERIFIED; GLUCAGON; HUMAN GROWTH HORMONE; HUMANS; HYDROCORTISONE; HYPOGLYCEMIC AGENTS; INSULIN; ISLETS OF LANGERHANS; KETONES; MIDDLE AGED; NOREPINEPHRINE;

EID: 25844517129     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2005.01660.x     Document Type: Article

References (30)

1. Ipp E, Westhoff T. Diabetes mellitus and the critically ill patient. In Bongard S ed. Current Diagnosis and Treatment in Critical Care, 2nd edition. New York: Lange and McGraw Hill, 2002.
2. Kitabchi AE, Umpierrez GE, Murphy MB, Barrett EJ, Kreisberg RA, Malone JI et al. Management of hyperglycemic crises in patients with diabetes. Diabetes Care 2001; 24: 131-153.
3. McGarry JD, Foster DW. Regulation of hepatic fatty acid oxidation and ketone body production. Ann Rev Biochem 1980; 49: 395-420.
4. Winter WE, Maclaren NK, Riley WJ, Clarke DW, Kappy MS, Spillar RP. Maturity-onset diabetes of youth in black Americans. N Engl J Med 1987; 316: 285-291.
5. Banerji MA, Chaiken RL, Huey H, Tuomi T, Norin AJ, Mackay IR et al. GAD antibody negative NIDDM in adult black subjects with diabetic ketoacidosis and increased frequency of human leukocyte antigen DR3 and DR4. Diabetes 1994; 43: 741-745.
6. Umpierrez GE, Casals MM, Gebhart SP, Mixon PS, Clark WS, Phillips LS. Diabetic ketoacidosis in obese African-Americans. Diabetes 1995; 44: 790-795.
7. Wilson C, Krakoff J, Gohdes D. Ketoacidosis in Apache Indians with non-insulin-dependent diabetes mellitus. Arch Intern Med 1997; 157: 2098-2101.
8. Balasubramanyam A, Zern JW, Hyman DJ, Pavlik V. New profiles of diabetic ketoacidosis: type 1 vs. type 2 diabetes and the effect of ethnicity. Arch Intern Med 1999; 159: 2317-2322.
9. Maldonado M, Hampe CS, Gaur LK, D'Amico S, Iyer D, Hammerle LP et al. Ketosis-prone diabetes: dissection of a heterogeneous syndrome using an immunogenetic and β-cell functional classification, prospective analysis and clinical outcomes. J Clin Endocrinol Metab 2003; 88: 5090-5098.
10. Linfoot PA, Ipp E. Ketoacidosis in Type 2 diabetes mellitus: presence of insulin deficiency. Proceedings of the Endocrine Society Meeting 1993.
11. Aizawa T, Katakura M, Taguchi N, Kobayashi H, Aoyagi E, Hashizume K et al. Ketoacidosis-onset noninsulin dependent diabetes in Japanese subjects. Am J Med Sci 1995; 310: 198-201.
12. Zouvanis M, Pieterse AC, Seftel HC, Joffe BI. Clinical characteristics and outcome of hyperglycaemic emergencies in Johannesburg Africans. DiabetMed 1997; 14: 603-606.
13. Tan KC, Mackay IR, Zimmet PZ, Hawkins BR, Lam KS. Metabolic and immunologic features of Chinese patients with atypical diabetes mellitus. Diabetes Care 2000; 23: 335-338.
14. Pitteloud N, Philippe J. Characteristics of Caucasian type 2 diabetic patients during ketoacidosis and at follow-up. Schweiz Med Wochenschr 2000; 130: 576-582.
15. Yu E, Guo H, Wu T. Factors associated with discontinuing insulin therapy after diabetic ketoacidosis in adult diabetic patients. Diabet Med 2001; 18: 895-899.
16. Sobngwi E, Vexiau P, Levy V, Lepage V, Mauvais-Jarvis F, Leblanc H et al. Metabolic and immunogenetic prediction of long-term insulin remission in African patients with atypical diabetes. Diabet Med 2002; 19: 832-835.
17. Umpierrez GE, Woo W, Hagopian WA, Isaacs SD, Palmer JP, Gaur LK et al. Immunogenetic analysis suggests different pathogenesis for obese and lean African-Americans with diabetic ketoacidosis. Diabetes Care 1999; 22: 1517-1523.
18. Goldman L, Bennett JC. Cecil Textbook of Medicine, 21st edn. Philadelphia: W.B. Saunders, 2000: 1263.
19. Hother-Nielsen O, Faber O, Sorensen NS, Beck-Nielsen H. Classification of newly diagnosed diabetic patients as insulin-requiring or non-insulin-requiring based on clinical and biochemical variables. Diabetes Care 1988; 11: 531-537.
20. Center P, Berman N, Jacob M, Ipp E. Counterregulatory hormones oscillate during steady state hypoglycemia. Am J Physiol 1998; 275: E821-829.
21. Ipp E, Sinai Y, Forster B, Cortez C, Baroz B, Nesher R et al. A glucose reduction challenge in the differential diagnosis of fasting hypoglycemia: a two center study. J Clin Endocrinol Metab 1990; 70: 711-717.
22. Cooper DM, Barstow TJ, Lee W-NP. Blood glucose turnover during high and low intensity exercise. Am J Physiol 1989; 257: E405-E412.
23. Falholt K, Lund B, Falholt W. An easy colorimetric micromethod for routine determination of free fatty acids in plasma. Clin Chim Acta 1973; 46: 105-111.
24. Neufeld M, Maclaren NK, Riley WJ, Lezotte D, McLaughlin JV, Silverstein J et al. Islet cell and other organ-specific antibodies in U.S. Caucasians and Blacks with insulin-dependent diabetes mellitus. Diabetes 1980; 29: 589-592.
25. Chupin M, Charbonnel B, Chupin F. C-peptide blood levels in ketoacidosis and in hyperosmolar non-ketotic diabetic coma. Acta Diabet Lat 1981; 18: 123-128.
26. Unger RH, Grundy S. Hyperglycemia as an inducer as well as a consequence of impaired islet cell function and insulin resistance: implications for management of diabetes. Diabetologia 1985; 28: 119-121.
27. Leahy JR, Cooper HE, Deal DA, Weir GC. Chronic hyperglycemia is associated with impaired glucose influence on insulin secretion: a study in normal rats using chronic in vivo glucose infusions. J Clin Invest 1986; 77: 908-915.
28. Plavinik FL, Rodrigues CIS, Zanella MT, Ribiero AB. Hypokalemia, glucose intolerance, and hyperinsulinemia during diuretic therapy. Hypertension 1992; 19 (Suppl. II): 26-29.
29. Burge MR, Hardy KJ, Schade DS. Short-term fasting is a mechanism for the development of euglycemic ketoacidosis during periods of insulin deficiency. J Clin Endocrinol Metab 1993; 76: 1192-1198.
30. Fulop M. Alcoholic ketoacidosis. Endocrinol Metab Clinics 1993; 22:209-219.